Muhammad Asif, Ph.D. has been named director of analytical development, and Paul Maffuid, Ph.D. has been named senior vice president of operations, Irvine Pharmaceutical Services.

Dr. Asif has more than 17 years of experience including supporting the development of pharmaceutical products through his various roles at MannKind Corp., DEY, L.P. (an associate of Merck KGaA), Wyeth, and Fujisawa, USA. His expertise ranges from analytical method development and validation to extractables/leachables, product characterization studies and preparation of analytical portions of the CMC sections of INDs, NDAs and ANDAs.

Dr. Maffuid has 20 years of experience in the pharmaceutical industry having worked at various companies, including Arena Pharmaceuticals, Inc., Magellan Laboratories, Inc., Cabrillo Laboratories, Amylin Pharmaceuticals, Inc., Glaxo research, California Biotechnology and Syntex, Inc. He is a member of the American Association of Pharmaceutical Scientists and the American Chemical Society, and has authored several publications.

Irvine Pharmaceutical Services welcomes Dr. Maffuid and Dr. Asif as part of the company's ongoing efforts to continually improve its client services through employment of unparalleled professionals. "I am proud to have Dr. Maffuid and Dr. Asif join our staff," said Assad J. Kazeminy, chief executive officer and founder of Irvine Pharmaceutical Services. "Each brings an impressive depth of knowledge and experience, which I am confident will prove invaluable to our current and future clients."

News from our sister sites